Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-15

FDA Approved: EXEMESTANE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Exemestane from Breckenridge Pharmaceutical, Inc. The approval pertains to the generic product under the ANDA pathwa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)